ArticleHaematologica2021

Comment on "Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study."

Marco Picardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.